ResearcherUniversity of GrazNo recent work listed
Wael Al Zoughbi
Matched on ORCID iD 0000-0002-0684-1180; OpenAlex author ID A5067091673. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper
Papers 3
- Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1159/000492433↗
- Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Co-author DOI 10.1038/bjc.2013.332↗
- External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients. Co-author DOI 10.1371/journal.pone.0078225↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Martin Pichler Pichler · 3 shared papers, 2013–2018 · strength 0.18
- Paper Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adeno… DOI 10.1159/000492433↗
- Paper Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable panc… DOI 10.1038/bjc.2013.332↗
- Paper External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreati… DOI 10.1371/journal.pone.0078225↗
- Gerald Höefler · 3 shared papers, 2013–2018 · strength 0.18
- Paper Early Loss of Forkhead Transcription Factor, O Subgroup, Member 1 Protein in the Development of Pancreatic Ductal Adeno… DOI 10.1159/000492433↗
- Paper Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable panc… DOI 10.1038/bjc.2013.332↗
- Paper External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreati… DOI 10.1371/journal.pone.0078225↗
- Michael Stotz · 2 shared papers, 2013 · strength 0.06
- Paper Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable panc… DOI 10.1038/bjc.2013.332↗
- Paper External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreati… DOI 10.1371/journal.pone.0078225↗
- Joanna Szkandera · 2 shared papers, 2013 · strength 0.06
- Paper Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable panc… DOI 10.1038/bjc.2013.332↗
- Paper External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreati… DOI 10.1371/journal.pone.0078225↗
- Armin Gerger · 2 shared papers, 2013 · strength 0.06
- Paper Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable panc… DOI 10.1038/bjc.2013.332↗
- Paper External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreati… DOI 10.1371/journal.pone.0078225↗
- Peter Kornprat · 2 shared papers, 2013 · strength 0.06
- Paper Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable panc… DOI 10.1038/bjc.2013.332↗
- Paper External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreati… DOI 10.1371/journal.pone.0078225↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.